Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Camden Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Camden Partners

Camden Partners

Operating

Baltimore-based private equity firm offering growth, seed capital, and human capital in key sectors.

Location
Baltimore, MD, US
Founded
1995
Firm
Compare
Portfolio
Employees

Investments

Ceipal
Ceipal

Total Raised

$29.8M

Rounds

4

Series B$16.5MJune 2022
Roshal Imaging Services
Roshal Imaging Services

Total Raised

$8M

Rounds

1

Private Equity$8MOctober 2020
eFileCabinet
eFileCabinet

Total Raised

$48.4M

Rounds

6

Series C$11.5MSeptember 2020
Thrive Earlier Detection
Thrive Earlier Detection

Total Raised

$367M

Rounds

3

Series B$257MJuly 2020
Series A$110MMay 2019
LifeSprout
LifeSprout

Total Raised

$35.8M

Rounds

4

Series A$28.5MApril 2020
Conquer
Conquer

Total Raised

$26.1M

Rounds

5

Series B$10MJanuary 2020
RocketDocs
RocketDocs

Total Raised

$3.7M

Rounds

5

Convertible NoteDecember 2019
Private EquityJune 2018
Private EquityMarch 2015
Viventium
Viventium

Total Raised

$5M

Rounds

3

Private EquityOctober 2019
Private Equity$5MJuly 2018
Redpoint Global
Redpoint Global

Total Raised

$37.2M

Rounds

4

Series D$13.5MSeptember 2019
Catalyte
Catalyte

Total Raised

$65M

Rounds

11

Convertible NoteJuly 2019
Spiral Therapeutics
Spiral Therapeutics

Total Raised

$18.5M

Rounds

5

Series A$5.6MDecember 2018
Sisu Global Health
Sisu Global Health

Total Raised

$5.7M

Rounds

6

Convertible Note$1.2MSeptember 2018
Seed$1.1MSeptember 2016
Windmil Therapeutics
Windmil Therapeutics

Total Raised

$42.5M

Rounds

2

Series B$32.5MJune 2018
eNeura Therapeutics
eNeura Therapeutics

Total Raised

$75.8M

Rounds

14

Series D$17MFebruary 2018
Bluefin Payment Systems
Bluefin Payment Systems

Total Raised

$31M

Rounds

3

Series Unknown$6MMarch 2016
LifeNexus
LifeNexus

Total Raised

$24.9M

Rounds

8

Series A$12.6MJuly 2014
Essence Group Holdings
Essence Group Holdings

Total Raised

$407M

Rounds

4

Private Equity$71MMay 2014
Triumph Higher Education Group
Triumph Higher Education Group

Total Raised

$22.6M

Rounds

5

Private EquityJanuary 2014
Metabolon
Metabolon
Public

Total Raised

$199.7M

Rounds

14

Series E$15MJanuary 2014
Ingo Money
Ingo Money

Total Raised

$26.1M

Rounds

4

Private Equity$8.4MOctober 2013